COMMONWEALTH EQUITY SERVICES, LLC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 131 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$36,000
-12.2%
10,684
-2.3%
0.00%
Q2 2018$41,000
-6.8%
10,9340.0%0.00%
Q1 2018$44,000
-13.7%
10,9340.0%0.00%
Q4 2017$51,00010,9340.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders